Prev Chronic Dis by Pinheiro, Paulo S. et al.
PREVENTING  CHRONIC  DISEASE
P U B L I C  H E A L T H  R E S E A R C H ,  P R A C T I C E ,  A N D  P O L I C Y 
  Volume 16, E83                                                                         JUNE 2019  
 
ORIGINAL RESEARCH
 
 
Risk of Cancer Death Among White, Black, and
Hispanic Populations in South Florida
 
Paulo S. Pinheiro, MD, PhD1; Karen E. Callahan, MPH2; Tulay Koru-Sengul, PhD1; Justine Ransdell, BSc3;
Layla Bouzoubaa, MSPH1; Clyde P. Brown, DrPH4; Erin Kobetz, PhD1
 
Accessible Version: www.cdc.gov/pcd/issues/2019/18_0529.htm
Suggested  citation  for  this  article:  Pinheiro PS,  Callahan KE,
Koru-Sengul T, Ransdell J, Bouzoubaa L, Brown CP, et al.  Risk
of Cancer Death Among White, Black, and Hispanic Populations
in South Florida. Prev Chronic Dis 2019;16:180529. DOI: https://
doi.org/10.5888/pcd16.180529.
PEER REVIEWED
Summary
What is already known on this topic?
Compared with white Americans, cancer mortality rates are higher among
black Americans and lower among Hispanic Americans.
What is added by this report?
White and black residents of South Florida have lower cancer mortality
rates than their national counterparts, and the advantage for black South
Floridians results from the large number of Afro-Caribbean residents, who
have low risk for cancer mortality. Hispanics in South Florida, most of
whom are Cuban, have higher mortality rates for most cancers than their
national counterparts.
What are the implications for public health practice?
Effective cancer prevention and control efforts should be specific to popu-
lations to account for diversity.
Abstract
Background
The cancer burden in South Florida, with a population of more
than 6 million with a heavily Hispanic and large Afro-Caribbean
population, has not been quantified.
Methods
We analyzed 2012–2016 cancer mortality data from South Florida
for white, Hispanic, and black populations with disaggregation for
Cuban, Puerto Rican, South American, African American, and
Afro-Caribbean groups. We calculated cancer site-specific and all-
sites combined age-adjusted mortality rates, and we used negative
binomial regression to determine mortality rate ratios to compare
South Florida’s cancer mortality rates with those of the rest of the
nation.
Results
We analyzed 53,837 cancer deaths. Per 100,000 population, can-
cer mortality rates in South Florida were similar among white (173
per 100,000) and black (176 per 100,000) men and among white
and black women (133 for both), and they were lowest among
Hispanic men (151 per 100,000) and women (93 per 100,000).
However, compared with their counterparts nationally, Hispanic
residents  in  South  Florida  had  higher  cancer  mortality  rates,
largely  driven by Cuban residents,  and mortality  rates  among
white and black residents, especially male residents, were substan-
tially lower. Liver cancer rates were high among white and Puerto
Rican “baby boomers”; lung cancer mortality was low among all
groups except Cuban men; cervical cancer was high among white,
black, and Puerto Rican women.
Conclusion
Cancer patterns are not monochromatic in all US regions; South
Florida is distinctive. Meeting the needs of an aging diverse popu-
lation presents challenges for all major metropolitan areas. Ex-
panding surveillance, increasing minority participation in clinical
trials, and investing in culturally specific community-based health
promotion must continue.
Introduction
As cancer prevalence rises among the increasingly diverse US
population, targeted and culturally specific community-based can-
cer prevention and control efforts are required. Ideally, these will
be based on the most current knowledge of the population-specif-
ic cancer burden, including disparities, for a specific geographic
area  (1).  South  Florida  is  the  eighth  largest  metropolis  in  the
United States and is growing; it has more than 6 million residents
and comprises nearly one-third of Florida’s total population. South
Florida is  a gateway to Latin America and the Caribbean, and
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demographics reflect this: 44% of residents are Hispanic, 32% are
white, and 21% are black (2). The diversity extends intra-racially;
33% of black residents in South Florida are Afro-Caribbean, many
from Haiti and Jamaica (2). Likewise, the Hispanic population in
South Florida, born primarily outside of the continental United
States, differs vastly from the predominantly Mexican-origin His-
panic US population. Cubans are the largest Hispanic group in
South Florida, also home to large South American, Central Ameri-
can, and Puerto Rican populations (2).
Cancer is the leading cause of death for Hispanics and Afro-Carib-
beans in Florida (3,4) as well as elsewhere in the United States
(5,6). Yet no studies to date have analyzed cancer death rates in
South Florida, the catchment area of the Sylvester Comprehensive
Cancer  Center  at  the  University  of  Miami,  which  includes
Broward, Miami-Dade, Monroe, and Palm Beach counties. Thus,
our objective was to characterize patterns of cancer deaths by race/
ethnicity in South Florida and compare rates between South Flor-
ida and the United States. We hypothesized that the cancer mortal-
ity  rates  of  metropolitan  areas  would differ  from those  of  the
United States as a whole.
Methods
We analyzed 5 years of cancer mortality data (January 1, 2012,
through December 31, 2016) for Florida residents in the Miami-
Dade-Broward-Palm Beach metropolitan statistical  area.  Data
were obtained from the Florida Department of Health Vital Statist-
ics for this cross-sectional study. Deaths from Monroe County (n =
956) were not included because of lack of corresponding popula-
tion-specific denominators. Cancer sites were coded according to
the International Classification of Diseases, 10th Revision. We
analyzed common causes of cancer death (lung, breast, prostate,
colorectum, pancreas, endometrium, ovary, and liver);  cancers
with high mortality rates among Hispanic and black populations
(cervical,  stomach, and multiple myeloma);  and all-sites-com-
bined (ie, deaths from all cancers). Because of the high preval-
ence of premenopausal breast cancer among black women (3,5),
breast cancer was analyzed in 2 categories, using an age threshold
of 50 to approximate premenopausal and postmenopausal breast
cancer (7). Liver cancer is common among minorities (8), and re-
cent reports from California (9) and New York (5) have indicated
significant differences between people born before 1945 and the
1945–1965 birth cohort, which is subject to the Centers for Dis-
ease Control and Prevention’s (CDC’s) recommendation for one-
time hepatitis C (HCV) testing because of high HCV prevalence
(10). To approximate these 2 groups, we analyzed liver cancer
rates for people aged 50 to 69 years and for those aged 70 years or
older.
We carefully examined codes for race/ethnicity and birthplace, in-
cluding text fields, to accurately classify race/ethnicity (3,5,11).
We analyzed the total Hispanic population and separately ana-
lyzed the Cuban, Puerto Rican, South American, and Other His-
panic (Mexican,  Dominican,  Central  American,  and Spaniard)
populations. We analyzed the total non-Hispanic black population
(hereafter referred to as black) and separately analyzed the Afric-
an American (black, born in the United States) and Afro-Carib-
bean (black, born in the Caribbean) populations. Finally, we ana-
lyzed the non-Hispanic white population (hereafter referred to as
white). Black decedents born in Africa or other countries not stud-
ied here were included in the aggregate black rates but not studied
separately (n = 225). Also, because of low numbers, American In-
dian/Alaska Native, Asian, and Pacific Islander decedents were
not included in this study (n = 714).
We obtained population denominators for the tri-county region for
each  year  from  2012  to  2016  from  the  US  Census  Bureau’s
American Community Survey (2), assembled into populations cor-
responding with numerator data and aggregated. Hispanics who
were “not otherwise specified” from the census data (less than
2%) were bridged to each study population proportionately by age
group and sex.
Sex-specific,  annualized,  age-standardized (2000 US standard
population) cancer mortality rates for 2012–2016 were calculated
per 100,000 people using 18 age group bands, all 5-year except the
last (ie, aged ≥85).
For direct comparison with South Florida estimates, national can-
cer mortality rates for  2012 through 2014 were obtained from
CDC (11) (South Florida data were restricted to these 3 years for
comparability).  Age-adjusted site-specific mortality rate ratios
(MRRs) and corresponding 95% confidence intervals (CIs) were
computed for white,  black,  and Hispanic populations in South
Florida, using their corresponding racial/ethnic counterparts na-
tionally as the reference population. To account for the large num-
ber of foreign-born black decedents in South Florida, MRRs for
the aggregate black as well as the exclusively African American
populations were both computed. MMRs were computed using
negative binomial regression. Models included decedents aged 35
or older, except for prostate cancer and multiple myeloma, which
included decedents aged 45 or older.
Data management and statistical analyses were performed using
SPSS version 22.0 (IBM Corporation) and SAS version 9.4 (SAS
Institute, Inc). Ethical review resulting in exempt status was ob-
tained from the University of Miami institutional review board.
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Results
In 2012–2016, cancer was the primary cause of death for 53,837
South  Florida  residents,  of  whom  29,050  were  white  (54%),
16,918 Hispanic (31%), and 7,869 black (15%). The median age
of white decedents was 48 years; Hispanic decedents, 38 years;
and black decedents, 31 years. Ninety-five percent of Hispanic,
41% of black, and 12% of white decedents were born outside the
continental US (including Puerto Rico) (Table 1).
Lung cancer was the leading cause of cancer death for all male
groups except Afro-Caribbeans and other Hispanics, for whom
prostate  cancer  was  the  leading  cause  followed  by  lung  and
colorectal cancers. Prostate and colorectal cancers were the second
and third leading causes of cancer death for all other male groups,
apart from Puerto Ricans for whom liver cancer was the second
leading cause of cancer death, followed by prostate. Among fe-
male  decedents,  lung  and  breast  cancers  were  the  first  or  the
second leading cause of cancer death in all groups, followed by
colorectal  cancer as the third,  except for Afro-Caribbeans,  for
whom both breast and colorectal cancers preceded lung cancer
(Table 2).
African American male and female decedents had the highest all-
sites-combined cancer mortality rate among all groups, as well as
the highest rates for most cancers. Compared with white male and
female decedents in South Florida, all 4 disaggregated Hispanic
groups as well as Afro-Caribbeans had lower overall rates. His-
panics in aggregate had significantly higher mortality rates than
white South Floridians only for stomach (male and female) and
prostate cancers (P < .05). Afro-Caribbeans had significantly high-
er rates compared with whites for stomach, prostate, multiple my-
eloma, premenopausal breast, and endometrial cancers, but lower
rates for most other cancers, particularly lung cancer (Table 2).
For Hispanics, considerable heterogeneity was found in cancer
mortality rates. Liver cancer among Puerto Rican male decedents
was 15.0 per 100,000, compared with the lower rate of 6.4 among
Cubans and a rate of 8.8 per 100,000 among white decedents (ref-
erence group) in South Florida. Conversely, lung cancer rates for
Cuban male decedents were higher than for white male decedents,
45.0 compared with 42.4 per 100,000, whereas all female Hispan-
ic groups and male South American decedents and other Hispanic
decedents  had  markedly  lower  lung  cancer  rates  than  whites.
Cuban decedents also had high colorectal cancer rates. Low mor-
tality rates for most cancers were observed in South Americans
and the heterogeneous other Hispanics, except for stomach, pro-
state, and liver (especially aged ≥70 y) cancers (Table 2).
In comparison with the overall US Hispanic population, the all-
sites-combined risk of cancer death in South Florida was 11%
higher among Hispanic males (MRR, 1.11; 95% CI, 1.08–1.14)
and  approximately  equivalent  among Hispanic  females.  Con-
versely, compared with their corresponding counterparts nation-
ally, risk of cancer death in South Florida was significantly lower
among white males (10% lower), white females (5% lower), black
males (27% lower),  and black females (19% lower) (Table 3).
Comparison of South Florida’s African American population to
the overall US black population reduced the risk advantage from
27% to only 8% lower mortality for males, and no significant dif-
ference was found between African American females in South
Florida and black females in the United States (Table 3).
Compared with national data, risk of death from lung cancer was
20% lower for white and African American males in South Flor-
ida but 46% and 13% higher for Hispanic males and females, re-
spectively. Compared with their US counterparts, the cervical can-
cer mortality rate in South Florida was 24% higher among whites
and 71% higher among African Americans (Table 3).  Further-
more, white males had a 19% lower prostate cancer rate and a
10% lower colorectal cancer rate, and white females had a 12%
lower colorectal cancer rate and a 6% lower breast cancer rate than
their national counterparts.
The risk of liver cancer mortality among white males and females
in the age 50–69 group was significantly higher than their US
counterparts (23% and 28% higher in males and females, respect-
ively). For Hispanics aged 50 to 69 years, compared with their US
counterparts, substantial risk of death for lung cancer, prostate
cancer (16% higher), pancreatic cancer in males (15% higher), and
colorectal cancer in females (15% higher) was offset by a reduced
risk of liver cancer mortality, 52% and 44% lower for males and
females, respectively. Even among decedents aged 70 years or
older, liver cancer mortality was 36% lower for Hispanic men and
30% lower for Hispanic women than it was nationally (Table 3).
Discussion
Although South Florida cancer patterns generally align with the
epidemiology of cancer in the United States (ie, highest rates for
African  Americans,  lowest  rates  for  Hispanics,  and  rates  for
whites in between [5,12,13]), metropolitan-area–specific cancer
mortality rate disparities are evident. The densely populated and
increasingly diverse South Florida region has several unique as-
pects to its cancer burden.
Contrary to typical findings in the United States, no disparity in
overall cancer mortality was found between South Florida’s ag-
gregate black and white populations. Moreover, compared with
their counterparts nationally, white and black populations in South
Florida had lower cancer mortality rates and Hispanics had signi-
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ficantly higher rates. Careful scrutiny of the unique racial/ethnic
composition of South Florida’s black and Hispanic populations,
combined with a portrayal of the specific characteristics of the
white population, can provide perspective on these findings.
In this study, the low rates of cancer mortality among South Flor-
ida’s black population are almost entirely driven by the inclusion
of  low-risk  Afro-Caribbeans,  who  make  up  33%  of  South
Florida’s black (and 7% of the total) population (2). Analyzed sep-
arately, African Americans in South Florida experience cancer
mortality rates similar to those of African Americans in the United
States, with one notable exception: the lung cancer mortality rate
was 20% lower than among their black counterparts nationally, an
unexpected but encouraging finding. Although it is possible that
African American men in South Florida have a low prevalence of
current  and/or  past  smoking,  this  information is  not  currently
available by racial/ethnic group at a local level. Research is war-
ranted, as lung and other tobacco-driven cancers account for a siz-
able proportion of all cancer deaths. Among Afro-Caribbeans in
South Florida, the lower cancer mortality is consistent with prior
studies from Florida (3,4) and New York (5). Likewise, the previ-
ously reported (3,5) higher race-specific rates among both Afro-
Caribbean and African American populations for  endometrial,
prostate, premenopausal breast, and multiple myeloma cancers
were confirmed for South Florida’s black population in this study.
South Florida’s 33% white population had lower rates than their
counterparts nationally for all 4 leading causes of cancer death:
lung, prostate, breast, and colorectal. Socioeconomic indicators
likely explain this finding. The older white population had a medi-
an household income of $79,400 and a 67% prevalence of college
education  during  the  study  period,  higher  than  the  national
$72,000 and 54%, respectively. The favorable impact of higher so-
cioeconomic  status  on  cancer  indicators  has  been  well  docu-
mented (14–16). Higher income and education level in the United
States have generally been linked to lower prevalence of cancer
risk factors, including obesity (17) and smoking (18), resulting in
lower cancer incidence and better access to quality health care
(19), including cancer screening and high-quality cancer treat-
ment. In South Florida, lower incidence and higher survival com-
bined likely explain the lower mortality rates among whites. Non-
etheless,  the  overall  cancer  burden is  high,  with  nearly  6,000
deaths annually, because of the large number of older whites in the
region.  Moreover,  the  markedly  higher  liver  cancer  mortality
among the white “baby boomers” (ie, roughly equivalent to people
aged 50–69 years, approximating the cohort with high HCV pre-
valence) in South Florida merits special attention. Priority should
be placed on increasing compliance with one-time screening for
people born between 1945 and 1965 as recommended by CDC,
given that early identification and treatment of HCV infection can
prevent liver cancer (10).
The largest racial/ethnic group in South Florida is Hispanic, com-
prising 45% of the total population. The Hispanic cancer mortal-
ity rate in this region is predominantly driven by the Cuban popu-
lation, who are not only older (median age among Hispanics, 43 y)
but also have higher overall cancer mortality than other Hispanic
groups (4). Cubans are appreciably distinct from other Hispanic
groups, with a comparatively higher burden of colorectal, lung,
prostate, and breast cancers but markedly lower rates of cancers
caused by infectious agents (ie, cervical, liver, and stomach). Lung
cancer rates among Cuban males in South Florida surpass even
those of whites,  which may reflect the previously documented
high prevalence of smoking among Cuban males (20). Conversely,
liver cancer mortality is low for Cubans, with patterns distinct
from other racial/ethnic groups in South Florida. Cubans appear to
have neither the increased susceptibility for HCV-related liver
cancer documented for many Americans in the 50–69 age range,
nor the high rates typically seen among immigrant Hispanics older
than 70. In contrast, Puerto Rican men in South Florida have a
high liver cancer mortality rate; this is true both for those aged 50
to 69 years, concordant with the high prevalence of HCV among
Puerto Ricans (21,22), and for those older than 69 years, consist-
ent with the liver cancer mortality profile for Puerto Ricans in
New York (5). Notably, neither Hispanics in general, nor Puerto
Ricans in particular, are prioritized as a target group for interven-
tion in the current National Viral Hepatitis Plan (9); this oversight
should be re-examined.
The high prostate cancer mortality rate among Hispanics com-
pared with whites in South Florida and among African Americans
in South Florida in relation to US blacks is puzzling. Research is
needed to ascertain whether this stems from a truly higher risk of
aggressive prostate cancer among these groups or from survival
disparities resulting from differential access to quality health care
for prostate cancer, which requires a complex treatment protocol
(23).
Our population-based study benefits from its accurate disaggrega-
tion of Hispanic and black decedents into distinct groups with
unique  characteristics  that  affect  their  cancer  burden,  accom-
plished by having more than 99% of exact birthplace information
and specific race/ethnicity codes. Nonetheless, the limitations cus-
tomarily  found  in  descriptive  epidemiological  studies  apply.
Neither risk factor data nor screening and treatment information at
the individual  level  are  available  from mortality  data.  We ex-
amined cancer mortality, a function of cancer incidence and sur-
vival. Although our results are consistent with previously reported
cancer incidence patterns for Hispanic groups (24), limited health
care access and poor health care quality for some Hispanics may
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have resulted in poor cancer survival, thus affecting the mortality
burden. Unfortunately, the accuracy of survival data among the
foreign-born is prone to biases arising from passive follow-up
methods in cancer registries and missing information on birth-
place or Hispanic group (25,26). Future studies should attempt to
improve survival  estimation methods for  foreign-born,  mostly
minority populations.
This study shows heterogeneity in the cancer profile  of  South
Florida, indicated by examining differences by distinct racial/eth-
nic groups: the divergent liver cancer burden between Cuban and
Puerto Rican males is one such example. Addressing the cancer
prevention and control needs of this diverse population requires
leveraging this information in all community outreach and engage-
ment efforts, which could include targeted smoking interventions
for Cuban men, HCV testing and antiviral treatment especially for
Puerto Rican men and white “baby boomers,” and a continued fo-
cus on cervical cancer screening among all South Florida women.
Moreover, researchers have a unique opportunity in South Florida
to study the biologic and genetic mechanisms driving race-specif-
ic vulnerability for certain cancers among South Florida’s black
population, given its 2 distinct birthplace cohorts, African Ameri-
cans and Afro-Caribbeans.
Systematic collection of population-specific data taking into ac-
count the area’s extreme heterogeneity, as occurs in other equally
diverse areas of the country such as California (27) and New York
City (28), is lacking in Florida. Although some group-specific can-
cer research has been conducted in the area, these studies relied
primarily on relatively small samples (29,30). Cubans are most
disadvantaged by this gap in surveillance, as general data collec-
ted on US Hispanics is insufficient for meeting their needs. The
young composition of  South Florida’s  burgeoning population,
which comprises primarily Hispanics and blacks, provides oppor-
tunities for community-based and culturally specific lifestyle inter-
ventions,  especially  among  socioeconomically  disadvantaged
groups,  including  Central  Americans  and  Haitians,  to  control
South Florida’s future cancer burden. The unique cancer control
challenges facing South Florida, like other large US metropolitan
areas, require expansion of population-specific surveillance, in-
creased minority participation in clinical trials, and continued in-
vestment in community health education and promotion.
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Tables
Table 1. Population Characteristics, Study on Patterns of Cancer Deaths by Race/Ethnicity in South Florida, 2012–2016
Characteristic
Population Data (2) Cancer Data
Total
Population
Median Household
Income of Population, $
Median Age of
Population, y
No. of Cancer
Deaths
Foreign-Born
Decedents, %a
Top Country of Birth of
Decedents, %
White 1,889,467 79,400 48 29,050 12 United States, 88
Black, allb 1,237,215 46,700 31 7,869 41 United States, 59
African American 811,825 45,000 24 4,633 0 United States, 100
Afro-Caribbean 403,273 48,000 42 3,011 100 Haiti, 48
Hispanic, all 2,601,132 55,500 38 16,918 95 Cuba, 63
Cuban 1,107,542 54,100 43 10,920 98 Cuba, 98
South American 556,275 60,000 38 2,670 99 Colombia, 38
Puerto Rican 241,947 59,000 33 1,220 79 Puerto Rico, 79
Other Hispanicc 695,368 51,225 33 2,108 91 Nicaragua, 23
a Born outside of the 50 US states; includes birth on Island of Puerto Rico.
b Includes people of black/African descent not born in Caribbean countries or the United States.
c Includes decedents from Mexico, Central America, the Dominican Republic, and Spain.
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Table 2. Age-Adjusteda Mortality Rates for Selected Cancer Sites, Study on Patterns of Cancer Deaths by Race/Ethnicity in South Florida, 2012–2016
Cancer type
White
Black Hispanic
All Black
African
American
Afro-
Caribbean All Hispanic Puerto Rican Cuban
South
American
Other
Hispanicb
Age-Adjusted Mortality Rate Per 100,000 (95% Confidence Interval)
Male
Stomach 2.9 (2.5–3.3) 7.8 (6.5–9.4) 7.8 (5.9–10.0) 7.8 (5.9–10.4) 4.9 (4.3–5.6) 6.7 (4.2–10.2) 3.9 (3.2–4.7) 7.4 (5.6–9.7) 5.2 (3.6–7.2)
Colorectal 15.4
(14.5–16.5)
19.6
(17.5–21.9)
22.6
(19.5–26.1)
15.4
(12.7–18.6)
15.0
(13.9–16.1)
12.4
(9.0–16.6)
16.0
(14.6–17.5)
13.1
(10.5–15.9)
13.0
(10.2–16.4)
Liverc 8.8 (8.1–9.5) 9.6 (8.2–11.2) 11.2
(9.1–13.7)
7.0 (5.2–9.4) 7.6 (6.9–8.4) 14.9
(11.1–19.7)
6.4 (5.5–7.4) 8.3 (6.2–10.8) 10.3
(7.8–13.4)
Aged 50–69 y 4.5 (4.0–5.0) 4.0 (3.3–4.9) 5.7 (4.5–7.2) 1.9 (1.2–3.3) 3.0 (2.5–3.4) 6.2 (4.2–8.9) 2.6 (2.1–3.3) 1.4 (0.8–2.3) 4.5 (3.2–6.0)
Aged ≥70 y 4.0 (3.6–4.5) 4.4 (3.3–5.7) 4.5 (2.9–6.4) 3.7 (2.3–5.8) 4.4 (3.8–5.0) 8.5 (5.4–12.6) 3.6 (2.9–4.3) 6.5 (4.5–8.9) 5.7 (3.5–8.4)
Pancreas 13.7
(12.8–14.6)
10.1
(8.6–11.8)
13.0
(10.6–15.7)
6.9 (5.2–9.3) 11.0
(10.0–11.9)
10.4
(7.2–14.5)
11.5
(10.3–12.8)
11.1
(8.8–13.9)
8.7 (6.3–11.5)
Lung 42.4
(40.9–44.0)
33.9
(31.1–36.9)
47.8
(43.1–52.8)
18.1
(15.3–21.6)
36.3
(34.6–38.0)
31.9
(26.1–38.7)
45.0
(42.7–47.5)
20.6
(17.3–24.2)
19.4
(15.6–23.7)
Prostate 14.6
(13.8–15.5)
37.9
(34.6–41.3)
39.9
(35.2–45.0)
34.4
(30.0–39.3)
17.7
(16.4–18.9)
13.7
(9.6–18.7)
18.1
(16.7–19.7)
15.9
(12.8–19.5)
23.6
(19.0–28.8)
Multiple
myeloma
3.0 (2.6–3.4) 6.7 (5.4–8.1) 7.8 (5.9–10.1) 5.4 (3.9–7.6) 3.5 (3.0–4.1) 5.1 (2.9–8.2) 2.9 (2.3–3.6) 3.9 (2.6–5.7) 5.8 (3.8–8.2)
All-sites-
combinedd
172.8
(169.7–176.1)
175.5
(168.8–182.2)
206.3
(196.1–216.7)
137.6
(128.8–147.0)
150.6
(147.2–154.2)
151.4
(138.0–165.6)
163.5
(158.9–168.2)
131.6
(123.0–140.6)
130.4
(120.4–140.8)
Female
Stomach 1.5 (1.2–1.8) 4.6 (3.8–5.5) 4.9 (3.6–6.3) 4.4 (3.3–6.3) 2.8 (2.4–3.2) 2.5 (1.3–4.3) 2.1 (1.6–2.7) 4.5 (3.3–5.9) 4.0 (2.8–5.4)
Colorectal 10.5
(9.8–11.4)
13.9
(12.5–15.5)
17.5
(15.1–20.1)
10.9
(9.2–13.3)
10.1
(9.4–10.9)
10.1
(7.4–13.4)
12.0
(10.9–13.2)
7.1 (5.6–8.9) 7.8 (6.1–9.8)
Liverc 3.8 (3.3–4.3) 4.3 (3.5–5.2) 5.2 (4.0–6.6) 3.3 (2.4–5.1) 4.2 (3.7–4.7) 4.7 (2.8–7.3) 3.6 (3.0–4.3) 5.1 (3.9–6.7) 6.4 (4.9–8.2)
Aged 50–69 y 1.5 (1.2–1.8) 1.7 (1.3–2.2) 2.6 (1.8–3.5) 0.9 (0.5–2.4) 1.1 (0.8–1.3) 0.7 (0.2–1.8) 0.9 (0.6–1.4) 1.0 (0.6–1.7) 1.6 (1.0–2.5)
Aged ≥70 y 2.1 (1.8–2.5) 2.3 (1.7–3.0) 2.3 (1.5–3.4) 2.0 (1.3–3.7) 2.9 (2.5–3.3) 4.0 (2.3–6.5) 2.3 (1.9–2.8) 3.9 (2.7–5.3) 4.5 (3.2–6.1)
Pancreas 10.0
(9.3–10.8)
10.1
(8.9–11.5)
12.7
(10.6–15.0)
7.3 (5.9–9.5) 7.1 (6.5–7.8) 8.2 (5.8–11.3) 7.2 (6.4–8.1) 7.2 (5.8–9.0) 7.0 (5.4–8.9)
Lung 34.8
(33.4–36.1)
18.5
(16.8–20.3)
28.8
(25.7–32.1)
9.1 (7.5–11.3) 14.4
(13.5–15.3)
14.1
(10.8–18.1)
16.5
(15.3–17.9)
14.0
(12.0–16.4)
9.7 (7.8–11.8)
Breast 20.2
(19.0–21.4)
25.7
(23.7–27.7)
30.7
(27.6–34.0)
20.5
(18.1–23.5)
14.6
(13.7–15.5)
16.2
(12.7–20.3)
15.5
(14.2–16.9)
12.4
(10.6–14.5)
13.1
(11.0–15.4)
Premenopaus-
ale
3.5 (2.9–4.3) 5.3 (4.4–6.4) 5.4 (4.1–7.0) 5.2 (4.0–7.2) 2.3 (1.9–2.7) 1.9 (0.8–3.5) 2.2 (1.6–3.2) 2.3 (1.6–3.2) 2.6 (1.8–3.6)
Postmenopaus-
al
16.6
(15.7–17.6)
20.3
(18.6–22.1)
25.3
(22.4–28.3)
15.3
(13.3–17.9)
12.3
(11.5–13.2)
14.3
(11.0–18.3)
13.3
(12.2–14.5)
10.1
(8.5–12.1)
10.5
(8.7–12.7)
Cervix 2.8 (2.3–3.3) 4.0 (3.2–4.8) 4.9 (3.7–6.4) 3.0 (2.1–4.6) 1.9 (1.6–2.3) 2.9 (1.6–4.8) 1.8 (1.4–2.5) 1.9 (1.2–2.8) 1.9 (1.2–2.9)
Endometrium 4.3 (3.8–4.8) 9.2 (8.1–10.5) 9.8 (8.0–11.7) 8.6 (7.1–10.7) 3.8 (3.3–4.3) 4.3 (2.6–6.6) 4.0 (3.3–4.7) 3.1 (2.2–4.2) 4.3 (3.1–5.8)
a Adjusted to the US 2000 standard population.
b Includes decedents from Mexico, Central America, the Dominican Republic, and Spain.
c Includes all ages.
d All-sites-combined includes all cancers, including those not listed here.
e Menopausal status approximated by use of age threshold of 50.
(continued on next page)
PREVENTING CHRONIC DISEASE VOLUME 16, E83
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY           JUNE 2019
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
8       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2019/18_0529.htm
(continued)
Table 2. Age-Adjusteda Mortality Rates for Selected Cancer Sites, Study on Patterns of Cancer Deaths by Race/Ethnicity in South Florida, 2012–2016
Cancer type
White
Black Hispanic
All Black
African
American
Afro-
Caribbean All Hispanic Puerto Rican Cuban
South
American
Other
Hispanicb
Age-Adjusted Mortality Rate Per 100,000 (95% Confidence Interval)
Ovary 7.3 (6.6–8.0) 5.7 (4.8–6.7) 6.0 (4.7–7.6) 5.3 (4.1–7.1) 4.9 (4.4–5.5) 5.5 (3.5–8.3) 5.6 (4.8–6.4) 4.8 (3.7–6.2) 3.3 (2.3–4.6)
Multiple
myeloma
2.0 (1.7–2.3) 4.2 (3.4–5.1) 3.7 (2.6–5.0) 4.6 (3.5–6.5) 2.0 (1.6–2.3) 2.3 (1.2–4.2) 1.9 (1.5–2.4) 2.4 (1.6–3.5) 1.6 (1.0–2.6)
All-sites-
combinedd
132.6
(129.9–135.4)
133.4
(128.9–138.1)
164.1
(156.7–171.8)
106.2
(99.5–113.4)
92.9
(90.6–95.2)
103.0
(93.8–112.9)
97.1
(93.9–100.4)
91.6
(86.2–97.2)
84.5
(78.8–90.4)
a Adjusted to the US 2000 standard population.
b Includes decedents from Mexico, Central America, the Dominican Republic, and Spain.
c Includes all ages.
d All-sites-combined includes all cancers, including those not listed here.
e Menopausal status approximated by use of age threshold of 50.
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Table 3. Mortality Rate Ratiosa for Selected Cancer Sites, by Race/Ethnicity, South Florida Compared With US Counterparts, Study on Patterns of Cancer Deaths by
Race/Ethnicity in South Florida, 2012–2014
Cancer type
White (Ref: US white) All Black (Ref: US black) African American (Ref: US black) All Hispanic (Ref: US Hispanic)
Mortality Rate Ratio (95% Confidence Interval)
Male
Stomach 0.84 (0.71–0.99) 0.94 (0.76–1.15) 1.00 (0.74–1.32) 0.79 (0.68–0.92)
Colorectal 0.90 (0.83–0.98) 0.83 (0.73–0.94) 1.08 (0.93–1.27) 1.06 (0.97–1.16)
Liver, aged 50–69 y 1.23 (1.09–1.40) 0.48 (0.38–0.61) 0.69 (0.52–0.91) 0.48 (0.40–0.58)
Liver, aged ≥70 y 1.04 (0.91–1.19) 0.75 (0.53–1.06) 0.81 (0.50–1.31) 0.64 (0.53–0.76)
Pancreas 1.05 (0.91–1.13) 0.64 (0.54–0.77) 0.86 (0.69–1.07) 1.15 (1.03–1.28)
Lung 0.80 (0.77–0.83) 0.56 (0.51–0.61) 0.80 (0.72–0.89) 1.46 (1.38–1.55)
Prostate 0.81 (0.75–0.80) 0.99 (0.89–1.09) 1.16 (1.01–1.32) 1.16 (1.06–1.26)
Multiple myeloma 0.79 (0.68–0.92) 0.98 (0.79–1.21) 1.00 (0.74–1.36) 1.09 (0.90–1.32)
All-sites-combinedb 0.90 (0.87–0.91) 0.73 (0.70–0.76) 0.92 (0.87–0.97) 1.11 (1.08–1.14)
Female
Stomach 0.94 (0.77–1.14) 1.10 (0.87–1.39) 1.19 (0.87–1.66) 0.79 (0.67–0.94)
Colorectal 0.88 (0.82–0.95) 0.89 (0.78–1.01) 1.00 (0.84–1.19) 1.15 (1.05–1.26)
Liver, aged 50–69 y 1.28 (1.02–1.60) 0.68 (0.48–0.98) 1.10 (0.73–1.65) 0.56 (0.42–0.74)
Liver, aged ≥70 y 1.06 (0.90–1.24) 0.83 (0.57–1.19) 0.71 (0.40–1.26) 0.70 (0.59–0.84)
Pancreas 1.04 (0.97–1.13) 0.73 (0.62–0.85) 0.90 (0.73–1.11) 0.98 (0.88–1.09)
Lung 0.96 (0.89–1.03) 0.58 (0.52–0.64) 0.91 (0.80–1.02) 1.13 (1.04–1.22)
Breast 0.94 (0.88–0.99) 0.89 (0.81–0.98) 1.12 (0.99–1.26) 1.06 (0.98–1.14)
Cervix 1.24 (1.02–1.50) 1.34 (1.08–1.66) 1.71 (1.30–2.23) 0.92 (0.75–1.13)
Endometrium 1.00 (0.88–1.13) 1.04 (0.89–1.23) 1.12 (0.90–1.40) 1.05 (0.90–1.22)
Ovary 0.99 (0.90–1.09) 0.89 (0.73–1.09) 1.02 (0.78–1.33) 1.02 (0.90–1.16)
Multiple myeloma 0.94 (0.81–1.11) 0.77 (0.61–0.97) 0.73 (0.52–1.03) 0.97 (0.79–1.18)
All-sites-combinedb 0.95 (0.91–0.98) 0.81 (0.78–0.85) 1.01 (0.95–1.06) 0.99 (0.96–1.03)
Abbreviations: CI, confidence interval; MMR, mortality rate ratio; Ref, reference group.
a MMRs derived from negative binomial regression including ages ≥35 except prostate and multiple myeloma, ≥45, and liver as described.
b All-sites-combined includes all cancers, including those not listed here.
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